Prostate Cancer - Results from #22420

Implementation of an image guided intensity-modulated protocol for post-prostatectomy radiotherapy: Planning data and acute toxicity outcomes - Abstract August 30, 2013

How will focal therapy fit in with existing treatments? - Abstract August 30, 2013

Respiratory-induced prostate motion using wavelet decomposition of the real-time electromagnetic tracking signal - Abstract August 30, 2013

Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning - Abstract August 30, 2013

Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients - Abstract August 30, 2013

Dietary factors and risk for advanced prostate cancer - Abstract August 30, 2013

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial - Abstract August 30, 2013

Metastatic castration-resistant prostate cancer: Integrating new learnings to optimise treatment outcomes - Abstract August 30, 2013

Painful boney metastases - Abstract August 29, 2013

Molecularly targeted agents as radiosensitizers in cancer therapy-focus on prostate cancer - Abstract August 29, 2013

Predictors of Gleason score upgrading in a large African-American population - Abstract August 29, 2013

The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in perspective - Abstract August 29, 2013

Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer - Abstract August 29, 2013

Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: Retrospective analysis of safety profile and effect on blood coagulation - Abstract August 29, 2013

Prostate-specific antigen testing: Men's responses to 2012 recommendation against screening - Abstract August 29, 2013

Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel - Abstract August 29, 2013

New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical - Abstract August 29, 2013

Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy - Abstract August 29, 2013

PSA-based screening for prostate cancer: A comparative analysis - Abstract August 29, 2013

The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: The North Carolina-Louisiana Prostate Cancer Project - Abstract August 29, 2013

Page 1122 of 1437